Innovative global cannabinoid company Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced recently Mike Gorenstein has been appointed by the Board of Directors as CEO, President and Chairman beginning March 21, 2022 as Kurt Schmidt retires. About Mike Gorenstein Mike […]